BioXcel Therapeutics, Inc. - Common Stock (BTAI)
$1.80
0.00 (0.00%)
BTAI Stock Quote Delayed 30 Minutes
BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024
BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
76.95M
PE Ratio
-0.84
EPS
-2.15
Volume (Avg. Vol.)
129
Day's Range
-
52-Week Range
$0.16 - $3.50
Dividend & Yield
N/A (N/A)
BTAI Stock Predictions, Articles, and BioXcel Therapeutics, Inc. - Common Stock News
Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today?
BioXcel Therapeutics stock is falling on Friday after the company announced plans for a proposed public offering of BTAI shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.
Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today?
BioXcel Therapeutics (BTAI) stock is taking a beating on Monday after the biopharmaceutical company announced major layoffs.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
4 Top Stock Trades for Thursday: MSFT, TWTR, BTAI, PXD
Microsoft, Twitter, BioXcel Therapeutics and Pioneer Natural Resources were our top stock trades for Thursday. Here's the trade now.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a look at the pre-market stock market movers for Wednesday with the biggest winners and losers.
The Story of 2020 … and Possibly 2021 … and What it Means for Your Investments
In the not-too-distant future, healthcare will look dramatically different from what we know today. From telemedicine to precision medicine to genetic therapy, the global healthcare industry is about to be shaken up like never before.
Technology Stock Profits Will Only Accelerate in the Post-Pandemic World
These must-own investing themes and stocks will continue to pick up steam as the world moves to a new normal after the coronavirus crisis.
Ignore the Coronavirus Panic and Stop Selling
Unsurprisingly, the mainstream media has it all wrong. The coronavirus isn't the end of the world. Stop selling and start profiting now.
